Treatment of mandibular central giant cell granuloma with administration of systemic calcitonin: A case report Cenrtal giant cell granuloma (CGCG) is a benign aggressive, destructive, intraosseous lesion of jaw that occurs before the age of 30 years and predominantly in females. Curettage is the most preferred therapy but in recent years also conservative therapy is commonly used. This report presents the treatment modality of 11 years old boy that had CGCG on mandibular molar area. The patient was examined clinically and radiologically and incisional biopsy was performed. CGCG was the definitive diagnosis and systemic calcitonin therapy was begun intranasally once a day and stretched 6 months. After 6 months and regression of the lesion size and callus formation was determined. For six years follow-up there wasn't any findings of recurrence, abnormal dental eruption or functional disturbance. SDHG therapy with systemic calcitonin to avoid functional and aesthetic deformities in young patients is a non-surgical, minimally invasive and preferred method of treatment. KEYWORDS Calcitonin, central giant cell granuloma, mandible ÖZ Mandibulada görülen santral dev hücreli granülomun sistemik kalsitonin uygulamasi ile tedavisi: Bir olgu sunumu * Bu makale 28 Mayıs-1 Haziran 2014 tarihinde Antalya' da düzenlenen 8. ACBID Uluslararası Kongresi'nde poster olarak tebliğ edilmiştir.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.